Announcement PDF Appendix 3H - Notification of cessation of securities Announcement Summary Entity name PARADIGM BIOPHARMACEUTICALS LIMITED.. Announcement Type New announcement Date of this announcement Friday April 26, 2024 Details of +securities that have ceased ASX +security code Security description PAR ORDINARY FULLY PAID PARAP ORDINARY FULLY PAID RESTRICTED Number of +securities that have ceased The +securities have ceased due to Date of cessation 501,570 Cancellation pursuant to an employee share scheme buy-back 26/04/2024 80,000 Cancellation pursuant to an employee share scheme buy-back 26/04/2024 Refer to next page for full details of the announcement Appendix 3H - Notification of cessation of securities 1/4 Appendix 3H - Notification of cessation of securities Part 1 - Announcement Details 1.1 Name of +Entity PARADIGM BIOPHARMACEUTICALS LIMITED.. We (the entity named above) provide the following information about our issued capital. 1.2 Registered Number Type Registration Number ACN 169346963 1.3 ASX issuer code PAR 1.4 The announcement is New announcement 1.5 Date of this announcement 26/4/2024 Appendix 3H - Notification of cessation of securities 2/4 Appendix 3H - Notification of cessation of securities Part 2 - Details of +equity securities or +debt securities that have ceased ASX +Security Code and Description PAR : ORDINARY FULLY PAID Quoted +equity securities or +debt securities that have ceased Number of securities that have ceased 501,570 Reason for cessation Cancellation pursuant to an employee share scheme buy-back Date of cessation 26/4/2024 Is the entity paying any consideration for the cessation? No Any other information the entity wishes to notify to ASX about the cessation? ASX +Security Code and Description PARAP : ORDINARY FULLY PAID RESTRICTED Unquoted +equity securities that have ceased Number of securities that have ceased 80,000 Reason for cessation Cancellation pursuant to an employee share scheme buy-back Date of cessation 26/4/2024 Is the entity paying any consideration for the cessation? No Any other information the entity wishes to notify to ASX about the cessation? Appendix 3H - Notification of cessation of securities 3/4 Appendix 3H - Notification of cessation of securities Part 3 - Issued capital following changes Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise: The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX) ASX +security code and description Total number of +securities on issue PAR : ORDINARY FULLY PAID 349,795,939 PARO : OPTION EXPIRING 30-NOV-2024 61,901,264 3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX) ASX +security code and description PARAAB : OPTION EXPIRING 09-FEB-2026 EX $0.65 PARAP : ORDINARY FULLY PAID RESTRICTED PARAAA : PERFORMANCE RIGHTS PARAT : ORDINARY FULLY PAID RESTRICTED Total number of +securities on issue 2,500,000 443,332 3,968,639 125,000 Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form. Appendix 3H - Notification of cessation of securities 4/4